Cartesian Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RNAC for the last quarter is 8.27 M USD, and it's 26.18% higher compared to the previous quarter. The net income of Q4 23 is -215.21 M USD.